No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
SNY Sanofi
- 46.250
- -1.280-2.69%
Close Jun 14 16:00 ET
- 46.960
- +0.710+1.54%
Post 18:20 ET
115.72BMarket Cap23.86P/E (TTM)
46.850High45.900Low3.80MVolume46.800Open47.530Pre Close175.88MTurnover0.17%Turnover Ratio20.03P/E (Static)2.50BShares53.45452wk High1.46P/B101.77BFloat Cap40.89752wk Low1.91Dividend TTM2.20BShs Float53.461Historical High4.13%Div YieldTTM2.00%Amplitude8.844Historical Low46.316Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Sanofi on Pace for Largest Percent Decrease Since October 2023 -- Data Talk
Sanofi Sponsored ADR (SNY) is currently at $45.96, down $1.57 or 3.3% --Would be lowest close since April 18, 2024, when it closed at $45.39 --On pace for largest percent decrease since Oct. 27, 202
CDC 'Preparing for the Possibility' Bird Flu Could Spread More Easily
Sanofi Hits 8-week Low
Exploring Three Top Dividend Stocks On Euronext Paris
Sanofi: Information Concerning the Total Number of Voting Rights and Shares – May 2024
Express News | World Health Organization Chief: At This Time, Who Continues To Assess Risk To Public Health From H5n1 As Low
Comments
The term 'GRANOLAS' was coined by Goldman Sachs in 2020 based on a loose acronym of the stocks' names. It includes GlaxoSmithKline, Roche, ASML, Nestlé, Novartis, Novo Nordisk, L'Oréal, LVMH, AstraZeneca, SAP and Sanofi.
1
$Novavax(NVAX.US$ sank more than 10% Monday as the vaccine-maker fell for a third straight session following a month-long run-up that boosted the stock more than 400%.
NVAX closed Monday at $16, down 11.9% for the day and 32.9% from the $23.86 19-month intraday high that it hit last Thursday.
Prior to the recent sell-off, Novavax had gained 438.6% between its $4.43 intraday low on May 9 and its $23.86 intraday peak on...
NVAX closed Monday at $16, down 11.9% for the day and 32.9% from the $23.86 19-month intraday high that it hit last Thursday.
Prior to the recent sell-off, Novavax had gained 438.6% between its $4.43 intraday low on May 9 and its $23.86 intraday peak on...
2
$Sanofi(SNY.US$
Alright, folks, let’s dive into the world of biotech drama. Shares of Novavax (NVAX) have been on a tear, continuing their climb on Monday after the company dropped some major news last week. They announced a licensing deal with Sanofi, and the stock shot up 47.6%, closing at $13.11. That's the highest it's been since December 2022.
But wait, there's more! Novavax shares had already doubled last Friday on this news, and over the past three months, t...
Alright, folks, let’s dive into the world of biotech drama. Shares of Novavax (NVAX) have been on a tear, continuing their climb on Monday after the company dropped some major news last week. They announced a licensing deal with Sanofi, and the stock shot up 47.6%, closing at $13.11. That's the highest it's been since December 2022.
But wait, there's more! Novavax shares had already doubled last Friday on this news, and over the past three months, t...
6
Meme stock volatility hit the market Monday, sending indexes higher, but shortly before noon EST, the market boomeranged back down. Just after the closing bell, the $S&P 500 Index(.SPX.US$ had fallen flatly 0.02%, the $Dow Jones Industrial Average(.DJI.US$ also declined 0.17%, and the $Nasdaq Composite Index(.IXIC.US$ climbed 0.28%.
MACRO
This week, investors can expect macroeconomic data prints in the form of PPI on Tuesday, and CPI prints Wednesd...
MACRO
This week, investors can expect macroeconomic data prints in the form of PPI on Tuesday, and CPI prints Wednesd...
+1
28
4
$Novavax(NVAX.US$
👉 Key Highlights:
📍 Novavax's shares jump 120% in premarket trading after announcing a deal with Sanofi.
📍 Partnership to co-commercialize Covid vaccine and develop combination flu shots.
📍 Sanofi to make an upfront payment of $500 million to Novavax, with potential for up to $700 million more.
📍 Deal includes royalties and up to $200 million in additional milestones.
📍 Sanofi acquires less than ...
👉 Key Highlights:
📍 Novavax's shares jump 120% in premarket trading after announcing a deal with Sanofi.
📍 Partnership to co-commercialize Covid vaccine and develop combination flu shots.
📍 Sanofi to make an upfront payment of $500 million to Novavax, with potential for up to $700 million more.
📍 Deal includes royalties and up to $200 million in additional milestones.
📍 Sanofi acquires less than ...
3
3
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg